Upgrade to SI Premium - Free Trial

Canaccord Reiterates Buy Rating on Boston Scientific (BSX)

July 28, 2026 5:24 AM
Canaccord analyst William Plovanic reiterated a Buy rating and $70.00 price target on Boston Scientific (NYSE: BSX)The analyst comments "Bottom ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments